Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia

Journal of the American College of Cardiology

Volumn 26, Issue 5, 1995, Pages 1340-1347

  Grayburn, Paul A ^a   Erickson, John M ^a   Escobar, Jose ^a   Womack, Leeann ^a   Velasco, Carlos E ^a  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUOROCARBON; PERFLUOROPENTANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DOG; EMULSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY; FLUOROCARBONS; HYDROCARBONS, FLUORINATED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0028864281     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00306-1     Document Type: Article

References (34)

1. Myocardial contrast two-dimensional echocardiography: a complement to coronary angiography
2. Myocardial contrast echocardiography in humans. I. Safety: a comparison with routine coronary arteriography
3. Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve
4. Functional significance of collateral blood flow in patients with recent acute myocardial infarction
5. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction
6. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
7. Illusion of reperfusion: does anyone achieve optimal reperfusion during acute myocardial infarction?
8. Myocardial opacification produced by peripheral venous injection of a new ultrasonic contrast agent
9. Success of myocardial contrast echocardiography by peripheral venous injection method: visualization of area at risk
10. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography: implications in determining extent of myocardial salvage
11. Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine
12. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion
13. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: role of neutrophil activation
14. Blood flow measurements with radionuclide-labeled particles
15. Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion
16. Cardioprotective action of endothelin-1 during ischemia
17. Preconditioning does not attenuate myocardial stunning
18. The “no-reflow” phenomenon after temporary coronary occlusion in the dog
19. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog
20. Contrast echocardiography in acute myocardial ischemia l In vivo determination of total left ventricular “area at risk”
21. Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium
22. Hydrogen peroxide contrastenhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion
23. Hydrogen peroxide contrast echocardiography: quantification in-vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion
24. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left atrial and right atrial injections of contrast
25. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast
26. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases
27. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography
28. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction
29. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
30. Time course of chamber and myocardial opacification with EchoGen: a videodensitometric study in monkeys with microvascular visualization studies in a cat mesentery model
31. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
32. Myocardial perfusion and ventricular function during total coronary artery occlusion in humans: a comparison with rest and exercise radionuclide studies
33. Demonstration of myocardial reperfusion injury in humans results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction
34. Evaluation of the efficacy, safety, and pharmacokinetics of QW 3600 (EchoGen) in man